Clinical Trial Update: A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body [Phase 1]

View source ↗

Summary

Phase 1 study to compare how two formulations of survodutide are absorbed in people with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Obesity | Phase 1 | Status: RECRUITING